[Candidiasis].
Maesaki
Shigefumi
S
Department of Infection Disease & Infection Control, Saitama Medical School.
Yamaguchi
Toshiyuki
T
D000935:Antifungal Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D003937:Diagnosis, Differential; D054714:Echinocandins; D015725:Fluconazole / Q000008:administration & dosage; D005936:Glucans / Q000097:blood; D006801:Humans; D055666:Lipopeptides; D008074:Lipoproteins / Q000008:administration & dosage; D000077551:Micafungin; D025202:Molecular Diagnostic Techniques; D010456:Peptides, Cyclic / Q000008:administration & dosage; D011379:Prognosis; D012698:Serologic Tests; D047071:beta-Glucans
D000935:Antifungal Agents; D015415:Biomarkers; D054714:Echinocandins; D005936:Glucans; D055666:Lipopeptides; D008074:Lipoproteins; D010456:Peptides, Cyclic; D047071:beta-Glucans; D015725:Fluconazole; C033363:beta-1,3-glucan; D000077551:Micafungin